[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [$spry](/topic/$spry) ### Top Social Posts *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "$SPRY $AQST ARS is studying use of Neffy with Urticaria. There are quite a few new drugs in development for this indication. The drug below was approved just weeks ago. They indicate that one-third of patients achieved complete absence of itch and hives at Week 12" [X Link](https://x.com/AscendingBio/status/1979896605269504218) [@AscendingBio](/creator/x/AscendingBio) 2025-10-19T13:05Z XXX followers, XXX engagements "@AscendingBio @AllenWoodMBA Dont listen to the noise. Federal Government shutdown is very unfortunate for $AQST Thank goodness $SPRY has US approvals and international approvals. Big head start to capture market LEAPS AND BOUNDS AHEAD" [X Link](https://x.com/northernboston/status/1978974648684380305) [@northernboston](/creator/x/northernboston) 2025-10-17T00:01Z XXX followers, XXX engagements "@Jonny_fun_guy @AscendingBio @MunsonBiotech "It's a tough market to gain traction in." Having been in that biz for a long time no truer words can be said. I have no concern with my earlier comments that $SPRY (and $AQST if approved) are REVOLUTIONARY devices for the food allergy market and will eventually take XX% share" [X Link](https://x.com/SmallCapKing2/status/1978842285732205044) [@SmallCapKing2](/creator/x/SmallCapKing2) 2025-10-16T15:15Z 3613 followers, XXX engagements "$SPRY weekly/monthly data continues to prove out mgmt's thesis about the temporary back-to-school weakness in share (NOT in absolute sales) as share has resumed its measured upward march in September and through the first week of October" [X Link](https://x.com/SmallCapKing2/status/1977774936166203686) [@SmallCapKing2](/creator/x/SmallCapKing2) 2025-10-13T16:34Z 3610 followers, 1260 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$SPRY $AQST ARS is studying use of Neffy with Urticaria. There are quite a few new drugs in development for this indication. The drug below was approved just weeks ago. They indicate that one-third of patients achieved complete absence of itch and hives at Week 12"
X Link @AscendingBio 2025-10-19T13:05Z XXX followers, XXX engagements
"@AscendingBio @AllenWoodMBA Dont listen to the noise. Federal Government shutdown is very unfortunate for $AQST Thank goodness $SPRY has US approvals and international approvals. Big head start to capture market LEAPS AND BOUNDS AHEAD"
X Link @northernboston 2025-10-17T00:01Z XXX followers, XXX engagements
"@Jonny_fun_guy @AscendingBio @MunsonBiotech "It's a tough market to gain traction in." Having been in that biz for a long time no truer words can be said. I have no concern with my earlier comments that $SPRY (and $AQST if approved) are REVOLUTIONARY devices for the food allergy market and will eventually take XX% share"
X Link @SmallCapKing2 2025-10-16T15:15Z 3613 followers, XXX engagements
"$SPRY weekly/monthly data continues to prove out mgmt's thesis about the temporary back-to-school weakness in share (NOT in absolute sales) as share has resumed its measured upward march in September and through the first week of October"
X Link @SmallCapKing2 2025-10-13T16:34Z 3610 followers, 1260 engagements
/topic/$spry/posts